Cited by

• Comprehensive Analysis and Experimental Validation of the Parkinson's Disease Lysosomal Gene ACP2 and Pan-cancer.

  Liang Y, Zhong G, Li Y, Ren M, Wang A, Ying M, Liu C, Guo Y, Zhang D. Liang Y, et al. Biochem Genet. 2024 Feb 3. doi: 10.1007/s10528-023-10652-x. Online ahead of print. Biochem Genet. 2024. PMID: 38310198
• Pathological and Therapeutic Advances in Parkinson's Disease: Mitochondria in the Interplay.

  Naren P, Cholkar A, Kamble S, Khan SS, Srivastava S, Madan J, Mehra N, Tiwari V, Singh SB, Khatri DK. Naren P, et al. J Alzheimers Dis. 2023;94(s1):S399-S428. doi: 10.3233/JAD-220682. J Alzheimers Dis. 2023. PMID: 36093711 Free PMC article. Review.
• A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells.

  Deen MC, Zhu Y, Gros C, Na N, Gilormini PA, Shen DL, Bhosale S, Anastasi N, Wang R, Shan X, Harde E, Jagasia R, Lynn FC, Vocadlo DJ. Deen MC, et al. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2200553119. doi: 10.1073/pnas.2200553119. Epub 2022 Jul 12. Proc Natl Acad Sci U S A. 2022. PMID: 35858317 Free PMC article.
• The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.

  Polinski NK, Martinez TN, Ramboz S, Sasner M, Herberth M, Switzer R, Ahmad SO, Pelligrino LJ, Clark SW, Marcus JN, Smith SM, Dave KD, Frasier MA. Polinski NK, et al. Dis Model Mech. 2022 Jun 1;15(6):dmm049192. doi: 10.1242/dmm.049192. Epub 2022 May 25. Dis Model Mech. 2022. PMID: 35419585 Free PMC article.
• Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.

  Hatton SL, Pandey MK. Hatton SL, et al. Int J Mol Sci. 2022 Jan 19;23(3):1089. doi: 10.3390/ijms23031089. Int J Mol Sci. 2022. PMID: 35163013 Free PMC article. Review.